Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3.

Authors

Rahul Banerjee, Hans Messersmith, Mohammad Ebraheem, Shaji Kumar, Rahul Seth, Latha Subramanian, Samer Al Hadidi, Saurabh Zanwar, Matthew C Cheung, Benjamin Derman, Lisa K Hicks

Published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages 101200JCO2602399. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website.

PMID:
42814948
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.